Aiming at the cure for some of the world’s most challenging infectious diseases
[:el] George Scangos is the chief executive officer and a member of the Board of Directors of Vir Biotechnology. He currently serves on the Boards of Directors of Agilent, Exelixis, and Decibel Therapeutics. Prior to this position, he was CEO at Biogen Idec, an American multinational biotechnology...